Generic placeholder image

Current Cancer Drug Targets


ISSN (Print): 1568-0096
ISSN (Online): 1873-5576

Mechanism of Drug Sensitivity and Resistance in Melanoma

Author(s): Caterina A.M. La Porta

Volume 9, Issue 3, 2009

Page: [391 - 397] Pages: 7

DOI: 10.2174/156800909788166574

Price: $65


Melanoma is the most aggressive form of skin cancer and advanced stages are inevitably resistant to conventional therapeutic agents. In particular, the inability of undergo apoptosis in response to chemotherapy and other external stimuli poses a selective advantage for tumor progression, metastasis formation as well as resistance to therapy in melanoma. Herein, we will review the molecular mechanisms of sensitivity and/or resistance of the most important drugs used in the treatment of melanoma. Furthermore, the novel strategies to overcome tumor chemoresistance will also be discussed. In particular, we will review the cancer stem cell hypothesis and how the failure of MDR reversal agents might increase the therapeutic index of substrate antineoplastic agents.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy